Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

Longitudinal Assessment of Nutritional Intervention in Inflammatory Bowel Disease Health Outcomes

Land Ho

What is the goal of the study?

Aim 1:To determine long-term clinical efficacy of the specific carbohydrate diet. Track standard clinical and laboratory outcomes for IBD over a 4-year period for patients on dietary and non-dietary treatments. Tract anthropometrics and nutritional laboratory outcomes over a 4-year period for patients on dietary and non-dietary treatments. Aim 2: Determine the phylogenetic and functional response of the gut microbiome to the SCD. This study will examine the effectiveness of SCD vs non SCD changes in microbial community structure by 16S rRNA gene sequencing and metagenomics, and expressed functions will be determined through a combination of metatranscriptomics and metaproteomics. Activities and organisms correlating with diet change or change in disease state (as determined by the clinical study) will be identified. Aim 3:Characterize the mechanism(s) of action of the SCD through metabolic profiling of the gut metabolome. Metabolomics of serum, urine and stool samples will be used to identify major metabolites under the different dietary regimes. Metabolites corresponding to particular disease states across patients will be correlated to the microbiome data in Aim 2 to determine the populations of bacteria involved in their production.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: